* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 23239 | PHLPP1 | C0007621 | Neoplastic Cell Transformation | 0.2 | CTD_human |
| 23239 | PHLPP1 | C0009375 | Colonic Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
| 23239 | PHLPP1 | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
| 23239 | PHLPP1 | C0027404 | Narcolepsy | 0.002407028523288 | GAD |
| 23239 | PHLPP1 | C0011881 | Diabetic Nephropathy | 0.002407028523288 | GAD |
| 23239 | PHLPP1 | C0699790 | Colon Carcinoma | 0.0010989071368524 | BEFREE |
| 23239 | PHLPP1 | C0007102 | Malignant tumor of colon | 0.0010989071368524 | BEFREE |
| 23239 | PHLPP1 | C1527249 | Colorectal Cancer | 0.0008241803526393 | BEFREE |
| 23239 | PHLPP1 | C0600139 | Prostate carcinoma | 0.0008241803526393 | BEFREE |
| 23239 | PHLPP1 | C2239176 | Liver carcinoma | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0376358 | Malignant neoplasm of prostate | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0033578 | Prostatic Neoplasms | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0024299 | Lymphoma | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0023434 | Chronic Lymphocytic Leukemia | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0017636 | Glioblastoma | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0009402 | Colorectal Carcinoma | 0.0005494535684262 | BEFREE |
| 23239 | PHLPP1 | C0242379 | Malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0235782 | Gallbladder Carcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0279626 | Squamous cell carcinoma of esophagus | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0280321 | Squamous cell carcinoma of the hypopharynx | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0346647 | Malignant neoplasm of pancreas | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0521530 | Lung consolidation | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0006142 | Malignant neoplasm of breast | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0678222 | Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0004114 | Astrocytoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C1306460 | Primary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0001418 | Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0235974 | Pancreatic carcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0178874 | Tumor Progression | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0153452 | Malignant neoplasm of gallbladder | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0007137 | Squamous cell carcinoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0007786 | Brain Ischemia | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0027627 | Neoplasm Metastasis | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0025202 | melanoma | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0009404 | Colorectal Neoplasms | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0020179 | Huntington Disease | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0018790 | Cardiac Arrest | 0.0002747267842131 | BEFREE |
| 23239 | PHLPP1 | C0017638 | Glioma | 0.0002747267842131 | BEFREE |